2021 Q4 Form 10-Q Financial Statement

#000152013822000017 Filed on January 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $20.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $65.00
YoY Change
% of Gross Profit
Operating Expenses $22.37K
YoY Change
Operating Profit -$22.37K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$22.37K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$22.37K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.0K
YoY Change
Cash & Equivalents $115.1K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $120.0K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $120.0K
Total Long-Term Assets $0.00
Total Assets $120.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $0.00
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $116.3K
YoY Change
Total Liabilities & Shareholders Equity $120.0K
YoY Change

Cashflow Statement

Concept 2021 Q4
OPERATING ACTIVITIES
Net Income -$22.37K
YoY Change
Depreciation, Depletion And Amortization $65.00
YoY Change
Cash From Operating Activities -$11.30K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $1.289K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.289K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$11.30K
Cash From Investing Activities -$1.289K
Cash From Financing Activities
Net Change In Cash -$12.48K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$11.30K
Capital Expenditures $1.289K
Free Cash Flow -$12.59K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
USD
CY2021Q3 us-gaap Liabilities
Liabilities
USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
USD
CY2021Q4 us-gaap Liabilities
Liabilities
USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q3 plasma Subscription Payable
SubscriptionPayable
USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD

Files In Submission

Name View Source Status
0001520138-22-000017-index-headers.html Edgar Link pending
0001520138-22-000017-index.html Edgar Link pending
0001520138-22-000017.txt Edgar Link pending
0001520138-22-000017-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plasma-20211130.xsd Edgar Link pending
plasma-20211130_10q.htm Edgar Link pending
plasma-20211130_10qex31z1.htm Edgar Link pending
plasma-20211130_10qex32z1.htm Edgar Link pending
plasma-20211130_10q_htm.xml Edgar Link completed
plasma-20211130_cal.xml Edgar Link unprocessable
plasma-20211130_def.xml Edgar Link unprocessable
plasma-20211130_lab.xml Edgar Link unprocessable
plasma-20211130_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending